Chi Sheng Pharma & Biotech Co., Ltd Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
August 09, 2023 at 04:13 pm
Share
Chi Sheng Pharma & Biotech Co., Ltd reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was TWD 265.87 million compared to TWD 280.86 million a year ago. Revenue was TWD 265.87 million compared to TWD 280.86 million a year ago. Net income was TWD 20.54 million compared to TWD 26.41 million a year ago. Basic earnings per share from continuing operations was TWD 0.36 compared to TWD 0.59 a year ago. Diluted earnings per share from continuing operations was TWD 0.36 compared to TWD 0.58 a year ago. Basic earnings per share was TWD 0.36 compared to TWD 0.46 a year ago. Diluted earnings per share was TWD 0.36 compared to TWD 0.46 a year ago.
For the six months, sales was TWD 529.04 million compared to TWD 556.73 million a year ago. Revenue was TWD 529.04 million compared to TWD 556.73 million a year ago. Net income was TWD 39.26 million compared to TWD 52.53 million a year ago. Basic earnings per share from continuing operations was TWD 0.69 compared to TWD 1.18 a year ago. Diluted earnings per share from continuing operations was TWD 0.69 compared to TWD 1.17 a year ago. Basic earnings per share was TWD 0.69 compared to TWD 0.92 a year ago. Diluted earnings per share was TWD 0.69 compared to TWD 0.92 a year ago.
Chi Sheng Pharma & Biotech Co., Ltd, formerly Chi Sheng Chemical Corporation is principally engaged in the manufacture and distribution of general medicines and medicinal injections. The Company provides injections, including hemodialysis concentrate, amino acid injection with electrolytes, vitamins, cephalosporin antibiotics, antihistamines and antipruritics, as well as ginkgo injections; oral preparations, including antibiotics, cold syrups and liquid antacid; external medicines, including contact lens fluid, normal saline for wash and povidone-iodine solution, and consumer goods, including functional health foods, skin care products and cosmetics. It also provides medical devices and equipment. The Company distributes its products in domestic markets and to overseas markets, including Mainland China and Southeast Asia.
CHI SHENG PHARMA & BIOTECH CO., LTD 
